• Pacific Biosciences held its annual meeting on June 3, 2026.
• Shareholders ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• A non-binding advisory resolution backing named executive officer compensation passed.
• Shareholders adopted an amendment to the 2020 Equity Incentive Plan to increase the shares reserved under the plan.
• Director nominees were chosen to serve until the 2027 annual meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Biosciences of California Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001299130-26-000092), on June 04, 2026, and is solely responsible for the information contained therein.